Renishaw PLC
LSE:RSW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (15.5), the stock would be worth GBX3 106.15 (30% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 22.2 | GBX4 452 |
0%
|
| 3-Year Average | 15.5 | GBX3 106.15 |
-30%
|
| 5-Year Average | 15.6 | GBX3 135.44 |
-30%
|
| Industry Average | 0 | GBX3.59 |
-100%
|
| Country Average | 0 | GBX3.94 |
-100%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
GBX2.9B
|
/ |
Jan 2026
£135.7m
|
= |
|
|
GBX2.9B
|
/ |
Jun 2026
£169.7m
|
= |
|
|
GBX2.9B
|
/ |
Jun 2027
£188.9m
|
= |
|
|
GBX2.9B
|
/ |
Jun 2028
£202.7m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Renishaw PLC
LSE:RSW
|
3.2B GBP | 22.2 | 43.7 | |
| JP |
|
Keyence Corp
TSE:6861
|
15.3T JPY | 23.9 | 36.7 | |
| US |
|
Keysight Technologies Inc
NYSE:KEYS
|
59.6B USD | 49.1 | 62 | |
| CN |
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
306.9B CNY | 15 | 20.5 | |
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
30B USD | 21.3 | 33.5 | |
| SE |
|
Hexagon AB
STO:HEXA B
|
274.2B SEK | 12.7 | 41.2 | |
| CN |
|
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
|
192.9B CNY | 2 350.2 | 1 890.2 | |
| TW |
|
Chroma ATE Inc
TWSE:2360
|
821.8B TWD | 81.4 | 70.3 | |
| UK |
|
Halma PLC
LSE:HLMA
|
16.8B GBP | 28.5 | 48.2 | |
| CN |
|
Huagong Tech Co Ltd
SZSE:000988
|
118.3B CNY | 76.3 | 80.4 | |
| US |
|
Trimble Inc
NASDAQ:TRMB
|
15.9B USD | 20.6 | 37.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 743.2 |
Other Multiples
Renishaw PLC
Glance View
Renishaw PLC began its journey in 1973, sparked by the innovative spirit of Sir David McMurtry and John Deer. Initially rooted in the creation of more precise measuring equipment, Renishaw has navigated technological mazes to become a global leader in measurement, healthcare, and manufacturing technologies. The spark that lit Renishaw’s torch was McMurtry's invention of the touch-trigger probe while working at Rolls-Royce, a defining moment that paved the way for the company’s focus on metrology: the science of measurement. Today, this niche expertise enables Renishaw to provide a multitude of industries—from aerospace to healthcare—with sophisticated solutions that enhance precision and efficiency across the globe. Renishaw’s financial health flourishes through its diverse yet intricately connected product offerings. Core to its business model is metrology, where it sells advanced systems and products like coordinate measuring machines, machine tool probes, and software. These products are vital for manufacturing companies seeking to ensure higher quality control and production efficiencies. Beyond metrology, Renishaw dabbles in healthcare, particularly in dental and neurological fields, with its innovative 3D printing technologies and stereotactic neurosurgery tools that offer new vistas in patient care. The synergy between traditional precision measurement and cutting-edge innovation amplifies its market presence, thus securing Renishaw’s place in both established and emerging industries.
